Cargando…
Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate
Caspases are a family of proteins mostly known for their role in the activation of the apoptotic pathway leading to cell death. In the last decade, caspases have been found to fulfill other tasks regulating the cell phenotype independently to cell death. Microglia are the immune cells of the brain r...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008626/ https://www.ncbi.nlm.nih.gov/pubmed/36906641 http://dx.doi.org/10.1038/s41419-023-05714-2 |
_version_ | 1784905796917657600 |
---|---|
author | Grabert, Kathleen Engskog-Vlachos, Pinelopi Škandík, Martin Vazquez-Cabrera, Guillermo Murgoci, Adriana-Natalia Keane, Lily Gaetani, Massimiliano Joseph, Bertrand Cheray, Mathilde |
author_facet | Grabert, Kathleen Engskog-Vlachos, Pinelopi Škandík, Martin Vazquez-Cabrera, Guillermo Murgoci, Adriana-Natalia Keane, Lily Gaetani, Massimiliano Joseph, Bertrand Cheray, Mathilde |
author_sort | Grabert, Kathleen |
collection | PubMed |
description | Caspases are a family of proteins mostly known for their role in the activation of the apoptotic pathway leading to cell death. In the last decade, caspases have been found to fulfill other tasks regulating the cell phenotype independently to cell death. Microglia are the immune cells of the brain responsible for the maintenance of physiological brain functions but can also be involved in disease progression when overactivated. We have previously described non-apoptotic roles of caspase-3 (CASP3) in the regulation of the inflammatory phenotype of microglial cells or pro-tumoral activation in the context of brain tumors. CASP3 can regulate protein functions by cleavage of their target and therefore could have multiple substrates. So far, identification of CASP3 substrates has been performed mostly in apoptotic conditions where CASP3 activity is highly upregulated and these approaches do not have the capacity to uncover CASP3 substrates at the physiological level. In our study, we aim at discovering novel substrates of CASP3 involved in the normal regulation of the cell. We used an unconventional approach by chemically reducing the basal level CASP3-like activity (by DEVD-fmk treatment) coupled to a Mass Spectrometry screen (PISA) to identify proteins with different soluble amounts, and consequently, non-cleaved proteins in microglia cells. PISA assay identified several proteins with significant change in their solubility after DEVD-fmk treatment, including a few already known CASP3 substrates which validated our approach. Among them, we focused on the Collectin-12 (COLEC12 or CL-P1) transmembrane receptor and uncovered a potential role for CASP3 cleavage of COLEC12 in the regulation of the phagocytic capacity of microglial cells. Taken together, these findings suggest a new way to uncover non-apoptotic substrates of CASP3 important for the modulation of microglia cell physiology. |
format | Online Article Text |
id | pubmed-10008626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-100086262023-03-13 Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate Grabert, Kathleen Engskog-Vlachos, Pinelopi Škandík, Martin Vazquez-Cabrera, Guillermo Murgoci, Adriana-Natalia Keane, Lily Gaetani, Massimiliano Joseph, Bertrand Cheray, Mathilde Cell Death Dis Article Caspases are a family of proteins mostly known for their role in the activation of the apoptotic pathway leading to cell death. In the last decade, caspases have been found to fulfill other tasks regulating the cell phenotype independently to cell death. Microglia are the immune cells of the brain responsible for the maintenance of physiological brain functions but can also be involved in disease progression when overactivated. We have previously described non-apoptotic roles of caspase-3 (CASP3) in the regulation of the inflammatory phenotype of microglial cells or pro-tumoral activation in the context of brain tumors. CASP3 can regulate protein functions by cleavage of their target and therefore could have multiple substrates. So far, identification of CASP3 substrates has been performed mostly in apoptotic conditions where CASP3 activity is highly upregulated and these approaches do not have the capacity to uncover CASP3 substrates at the physiological level. In our study, we aim at discovering novel substrates of CASP3 involved in the normal regulation of the cell. We used an unconventional approach by chemically reducing the basal level CASP3-like activity (by DEVD-fmk treatment) coupled to a Mass Spectrometry screen (PISA) to identify proteins with different soluble amounts, and consequently, non-cleaved proteins in microglia cells. PISA assay identified several proteins with significant change in their solubility after DEVD-fmk treatment, including a few already known CASP3 substrates which validated our approach. Among them, we focused on the Collectin-12 (COLEC12 or CL-P1) transmembrane receptor and uncovered a potential role for CASP3 cleavage of COLEC12 in the regulation of the phagocytic capacity of microglial cells. Taken together, these findings suggest a new way to uncover non-apoptotic substrates of CASP3 important for the modulation of microglia cell physiology. Nature Publishing Group UK 2023-03-11 /pmc/articles/PMC10008626/ /pubmed/36906641 http://dx.doi.org/10.1038/s41419-023-05714-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Grabert, Kathleen Engskog-Vlachos, Pinelopi Škandík, Martin Vazquez-Cabrera, Guillermo Murgoci, Adriana-Natalia Keane, Lily Gaetani, Massimiliano Joseph, Bertrand Cheray, Mathilde Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate |
title | Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate |
title_full | Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate |
title_fullStr | Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate |
title_full_unstemmed | Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate |
title_short | Proteome integral solubility alteration high-throughput proteomics assay identifies Collectin-12 as a non-apoptotic microglial caspase-3 substrate |
title_sort | proteome integral solubility alteration high-throughput proteomics assay identifies collectin-12 as a non-apoptotic microglial caspase-3 substrate |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008626/ https://www.ncbi.nlm.nih.gov/pubmed/36906641 http://dx.doi.org/10.1038/s41419-023-05714-2 |
work_keys_str_mv | AT grabertkathleen proteomeintegralsolubilityalterationhighthroughputproteomicsassayidentifiescollectin12asanonapoptoticmicroglialcaspase3substrate AT engskogvlachospinelopi proteomeintegralsolubilityalterationhighthroughputproteomicsassayidentifiescollectin12asanonapoptoticmicroglialcaspase3substrate AT skandikmartin proteomeintegralsolubilityalterationhighthroughputproteomicsassayidentifiescollectin12asanonapoptoticmicroglialcaspase3substrate AT vazquezcabreraguillermo proteomeintegralsolubilityalterationhighthroughputproteomicsassayidentifiescollectin12asanonapoptoticmicroglialcaspase3substrate AT murgociadriananatalia proteomeintegralsolubilityalterationhighthroughputproteomicsassayidentifiescollectin12asanonapoptoticmicroglialcaspase3substrate AT keanelily proteomeintegralsolubilityalterationhighthroughputproteomicsassayidentifiescollectin12asanonapoptoticmicroglialcaspase3substrate AT gaetanimassimiliano proteomeintegralsolubilityalterationhighthroughputproteomicsassayidentifiescollectin12asanonapoptoticmicroglialcaspase3substrate AT josephbertrand proteomeintegralsolubilityalterationhighthroughputproteomicsassayidentifiescollectin12asanonapoptoticmicroglialcaspase3substrate AT cheraymathilde proteomeintegralsolubilityalterationhighthroughputproteomicsassayidentifiescollectin12asanonapoptoticmicroglialcaspase3substrate |